Adjuvant therapy for gastric cancer - has the standard changed?VALLE, J. W.British journal of cancer. 2001, Vol 84, Num 7, pp 875-877, issn 0007-0920Article

Citrobacter freundii and fatal neutropenic enterocolitis following adjuvant chemotherapy for breast cancerCLEMONS, M. J; VALLE, J. W; HARRIS, M et al.Clinical oncology (Springer. Print). 1997, Vol 9, Num 3, pp 172-175, issn 0936-6555Conference Paper

Ultra-hight neutrinos and R-parity in superstring modelsVALLE, J. W. F.Physics letters. Section B. 1987, Vol 186, Num 1, pp 73-79, issn 0370-2693Article

Neutrino mass and new light gauge boson in superstring modelsVALLE, J. W. F.Physics letters. Section B. 1987, Vol 196, Num 2, pp 157-162, issn 0370-2693Article

Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortalityDOBSON, R; BURGESS, M. I; POSTON, G. J et al.British journal of cancer. 2014, Vol 111, Num 9, pp 1703-1709, issn 0007-0920, 7 p.Article

Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancerSHEIKH, H. Y; VALLE, J. W; WADDELL, T et al.British journal of cancer. 2008, Vol 99, Num 4, pp 577-583, issn 0007-0920, 7 p.Article

Pharmacokinetics of a hematoregulatory peptide (SK&F 107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapyZIA-AMIRHOSSEINI, P; HARRIS, R. Z; COWLEY, H. C et al.Pharmaceutical research. 2000, Vol 17, Num 4, pp 385-390, issn 0724-8741Article

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarkerKHOJA, L; BACKEN, A; VALLE, J. W et al.British journal of cancer. 2012, Vol 106, Num 3, pp 508-516, issn 0007-0920, 9 p.Article

Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United KingdomSHABARUDDIN, F. H; ELLIOTT, R. A; VALLE, J. W et al.British journal of cancer. 2010, Vol 103, Num 3, pp 315-323, issn 0007-0920, 9 p.Article

Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, pegylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volumeJAYSON, G. C; PARKER, G. J. M; BUCKLEY, D. L et al.Journal of clinical oncology. 2005, Vol 23, Num 5, pp 973-981, issn 0732-183X, 9 p.Article

A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancerCLAMP, A. R; SCHOFFSKI, P; JAYSON, G. C et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 4, pp 579-585, issn 0344-5704, 7 p.Article

Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer : a Phase I studySHEIKH, H. Y; VALLE, J. W; PALMER, K et al.British journal of cancer. 2007, Vol 96, Num 1, pp 38-43, issn 0007-0920, 6 p.Article

Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factorWHITWORTH, M. K; SHEEN, A; SHERLOCK, D et al.Journal of cancer research and clinical oncology. 2006, Vol 132, Num 1, pp 41-44, issn 0171-5216, 4 p.Article

Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancerSAUNDERS, M. P; HOGG, M; CARRINGTON, B et al.British journal of cancer. 2004, Vol 91, Num 8, pp 1447-1452, issn 0007-0920, 6 p.Article

Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trialsVALLE, J. W; FURUSE, J; JITLAL, M et al.Annals of oncology. 2014, Vol 25, Num 2, pp 391-398, issn 0923-7534, 8 p.Article

Second-line chemotherapy in advanced biliary cancer: a systematic reviewLAMARCA, A; HUBNER, R. A; RYDER, W. David et al.Annals of oncology. 2014, Vol 25, Num 12, pp 2328-2338, issn 0923-7534, 11 p.Article

A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancerMEYER, T; CAPLIN, M. E; KATO, H et al.European journal of cancer (1990). 2010, Vol 46, Num 3, pp 526-533, issn 0959-8049, 8 p.Article

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholanglocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 StudyVALLE, J. W; WASAN, H; GOLLINS, S et al.British journal of cancer. 2009, Vol 101, Num 4, pp 621-627, issn 0007-0920, 7 p.Article

Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinomaFALK, S; ANTHONEY, A; AJANI, J et al.British journal of cancer. 2006, Vol 95, Num 4, pp 450-456, issn 0007-0920, 7 p.Article

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD) : results of a phase II studyVALLE, J. W; DANGOOR, A; BEECH, J et al.British journal of cancer. 2005, Vol 92, Num 4, pp 628-630, issn 0007-0920, 3 p.Article

Models with a light sterile neutrino : reconciling the 17 keV anomaly with the solar neutrino deficitSMIRNOV, A. Y; VALLE, J. W. F.Nuclear physics. B. 1992, Vol 375, Num 3, pp 649-664, issn 0550-3213Article

The simplest model for the 17 keV neutrino and the MSW effectBENTO, L; VALLE, J. W. F.Physics letters. Section B. 1991, Vol 264, Num 3-4, pp 373-380, issn 0370-2693Article

Updated constraints on a new neutral gauge bosonGONZALEZ-GARCIA, M. C; VALLE, J. W. F.Nuclear physics. B. 1990, Vol 345, Num 2-3, pp 312-326, issn 0550-3213Article

Neutrino mass and baryon-number nonconservation in superstring modelsMOHAPATRA, R. N; VALLE, J. W. F.Physical review. D. Particles and fields. 1986, Vol 34, Num 5, pp 1642-1645, issn 0556-2821Article

Reconciling dark matter, solar and atmospheric neutrinosPELTONIEMI, J. T; VALLE, J. W. F.Nuclear physics. B. 1993, Vol 406, Num 1-2, pp 409-422, issn 0550-3213Article